Center for Devices and Radiological Health, Food and Drug Administration (FDA CDRH)
Federal agency
Each number links to the point's source. Points checked unless the point shows another date.
Remit
- CDRH is responsible for assuring that patients and providers have safe, effective and high-quality medical devices and safe radiation-emitting products, and aims to give industry predictable, consistent, transparent and efficient regulatory pathways.1
- Within CDRH, the Medical Device Cybersecurity division develops recommendations to improve medical device cybersecurity, responds to cybersecurity vulnerabilities and incidents, and works with public and private partners.2
Who it supervises
- A person who submits an application or submission under 21 U.S.C. 360(k), 360c, 360e(c), 360e(f) or 360j(m) for a cyber device must include the information FDA requires to ensure the device meets the cybersecurity requirements of section 524B (21 U.S.C. 360n-2(a)).3
- A cyber device is one that includes software validated, installed or authorized by the sponsor as a device or in a device, has the ability to connect to the internet, and contains any such technological characteristics that could be vulnerable to cybersecurity threats (21 U.S.C. 360n-2(c)).3
How it examines
- The policy in FDA's guidance on refusing to accept submissions for cyber devices expired on October 1, 2023; from that date FDA expects premarket submissions for cyber devices to contain the information section 524B requires.4
- FDA's Medical Device Cybersecurity Division asks to be emailed at Cybermed@fda.hhs.gov for help reporting a device cybersecurity vulnerability or incident; device-specific cybersecurity questions go through a pre-submission in FDA's Q-submission program.2
Technology and security guidance
- FDA's cybersecurity page says that on February 2, 2026 FDA issued the final guidance Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions, revised to align with the amendments to 21 CFR 820 (the Quality Management System Regulation).2 Compare: Medical device cybersecurity duties compared: manufacturers and hospitals
- FDA's guidance resources page lists the final premarket cybersecurity guidance, under its earlier title Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions, with the date February 3, 2026, and says it supersedes the guidance issued June 27, 2025.4 Compare: Medical device cybersecurity duties compared: manufacturers and hospitals
- Postmarket Management of Cybersecurity in Medical Devices, final guidance dated December 27, 2016, remains on FDA's list of cybersecurity guidance for manufacturers.4 Compare: Medical device cybersecurity duties compared: manufacturers and hospitals
- FDA's cybersecurity page lists, under October 24, 2024, a white paper FDA contracted on data normalization challenges and mitigations in software bill of materials (SBOM) processing.2
Recent rules
- Section 524B(b) of the FD&C Act requires a plan to monitor, identify and address postmarket cybersecurity vulnerabilities and exploits, including coordinated vulnerability disclosure; processes that give reasonable assurance the device and related systems are cybersecure, with postmarket updates and patches; and a software bill of materials covering commercial, open-source and off-the-shelf components. The section took effect 90 days after its enactment on December 29, 2022.3 Compare: Medical device cybersecurity duties compared: manufacturers and hospitals
- FDA states that the section 524B authority took effect on March 29, 2023.4
Enforcement
What the regulator's own pages say about its enforcement. Not a count or a pattern of actions.
- FDA publishes safety communications on device cybersecurity vulnerabilities. Its January 30, 2025 communication on two models of patient monitor (one a relabeled version of the other), updated July 2, 2025 after the manufacturer released a software patch, warned that the vulnerabilities could let unauthorized actors bypass cybersecurity controls, and said FDA was not aware of any related cybersecurity incidents, injuries or deaths.5
- In that case FDA said it and CISA continued to work with the manufacturer to correct the vulnerabilities, and said patients, caregivers and health care providers should not install the patch because installation requires specialized expertise.5
Official channels
Links to the regulator's own pages, checked .
Get the data: JSON
License: CC BY 4.0. Underlying government texts are public domain or under their own terms. Attribute "Moraph Insights" with a link to the page.
Sources
- U.S. Food and Drug Administration. Center for Devices and Radiological Health (content current as of 09/10/2026). Checked .
- U.S. Food and Drug Administration. Medical Device Cybersecurity (content current as of 11/10/2026). Checked .
- U.S. Government Publishing Office (govinfo). 21 U.S.C. 360n-2, Ensuring cybersecurity of devices (FD&C Act section 524B), U.S. Code 2024 edition. Checked .
- U.S. Food and Drug Administration. Cybersecurity Resources for Medical Device Manufacturers: Guidance, Resources, and FAQs (content current as of 11/10/2026). Checked .
- U.S. Food and Drug Administration. Cybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication (content current as of 07/02/2025). Checked .
How we source and check every fact: Editorial standards · Corrections
Last reviewed .
Spotted an error? Tell us and we will check it and correct the page where needed.